(Q74637084)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10092302%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10092302%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

1 reference

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10092302%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

3

K L Kotloff

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10092302%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

P Michetti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10092302%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

C Kreiss

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10092302%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

N Porta

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10092302%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

J L Blanco

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10092302%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

D Bachmann

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10092302%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

M Herranz

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10092302%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

P F Saldinger

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10092302%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

I Corthésy-Theulaz

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10092302%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

G Losonsky

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10092302%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

J Simon

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10092302%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

M Stolte

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10092302%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

S Ackerman

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10092302%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

T P Monath

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10092302%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

A L Blum

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10092302%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

language of work or name

English

0 references

publication date

1 April 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10092302%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10092302%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

116

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10092302%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10092302%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

804-812

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10092302%20AND%20SRC:MED&resulttype=core&format=json

Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970063-6

Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970063-6

Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970063-6

Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970063-6

Antimicrobial resistance and Helicobacter pylori

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970063-6

Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970063-6

Immunisation against gastric infection with Helicobacter species: first step in the prophylaxis of gastric cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970063-6

Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970063-6

The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970063-6

Development of a mouse model of Helicobacter pylori infection that mimics human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970063-6

Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970063-6

Therapeutic immunisation against Helicobacter infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970063-6

Therapeutic immunization against Helicobacter mustelae in naturally infected ferrets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970063-6

Gastric Colonization of the Ferret with Helicobacter Species: Natural and Experimental Infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970063-6

Safety of oral immunisation with recombinant urease in patients with Helicobacter pylori infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970063-6

Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970063-6

Gastritis in urease-immunized mice after Helicobacter felis challenge may be due to residual bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970063-6

Neonatal injection of native proton pump antigens induces autoimmune gastritis in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970063-6

Peripheral blood antibody-secreting cells in the evaluation of the immune response to an oral vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970063-6

Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970063-6

Protection by human milk IgA against Helicobacter pylori infection in infancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970063-6

Antibody responses in volunteers induced by nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970063-6

Galactose-binding site in Escherichia coli heat-labile enterotoxin (LT) and cholera toxin (CT)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970063-6

Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970063-6

Isolation and characterization of homogeneous heat-labile enterotoxins with high specific activity from Escherichia coli cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970063-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970063-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoPc expressing urease A and B subunits

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970063-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0016-5085(99)70063-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10092302%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference